A recent study reported that miRNA-330 overexpression in Alzheimer’s disease contributed to the reduction of amyloid β, oxidative stress, and mitochondrial dysfunction by targeting VAV1 through the MAPK pathway (Zhou et al., 2018). The gene discussed is VAV1; the disease is early-onset autosomal dominant Alzheimer disease.